Pienta Kenneth
Insider CIK 1571862 · CRIS Director · CUE Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CUE Cue Biopharma, Inc. | A Award deriv | 2022-03-25 | 2022-03-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2021-12-20 | 2021-12-21 | 80,000 | — | $0 | 80,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise deriv | 2021-03-16 | 2021-03-17 | 439 | — | $0 | 133,567 | SEC↗ |
| CUE Cue Biopharma, Inc. | S Sale | 2021-03-16 | 2021-03-17 | 439 | $15.09 | $6.6K | 2,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise | 2021-03-16 | 2021-03-17 | 439 | $5.00 | $2.2K | 2,439 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise deriv | 2021-03-15 | 2021-03-17 | 13,000 | — | $0 | 134,006 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise | 2021-03-15 | 2021-03-17 | 13,000 | $5.00 | $65.0K | 15,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | S Sale | 2021-03-15 | 2021-03-17 | 13,000 | $15.10 | $196.3K | 2,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise deriv | 2021-02-17 | 2021-02-18 | 1,280 | — | $0 | 0 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise deriv | 2021-02-17 | 2021-02-18 | 2,994 | — | $0 | 147,006 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise | 2021-02-17 | 2021-02-18 | 1,280 | $2.86 | $3.7K | 3,280 | SEC↗ |
| CUE Cue Biopharma, Inc. | S Sale | 2021-02-17 | 2021-02-18 | 4,274 | $15.06 | $64.4K | 2,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise | 2021-02-17 | 2021-02-18 | 2,994 | $5.00 | $15.0K | 6,274 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise deriv | 2021-02-16 | 2021-02-18 | 16,000 | — | $0 | 1,280 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise | 2021-02-16 | 2021-02-18 | 16,000 | $2.86 | $45.8K | 18,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | S Sale | 2021-02-16 | 2021-02-18 | 16,000 | $15.15 | $242.4K | 2,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2021-02-10 | 2021-02-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise deriv | 2021-01-20 | 2021-02-18 | 2,720 | — | $0 | 17,280 | SEC↗ |
| CUE Cue Biopharma, Inc. | P Buy | 2021-01-20 | 2021-01-22 | 2,720 | $15.07 | $41.0K | 4,720 | SEC↗ |
| CUE Cue Biopharma, Inc. | S Sale | 2021-01-20 | 2021-02-18 | 2,720 | $15.07 | $41.0K | 2,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise | 2021-01-20 | 2021-02-18 | 2,720 | $2.86 | $7.8K | 4,720 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2020-03-24 | 2020-03-26 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | P Buy | 2017-12-27 | 2018-01-19 | 2,000 | $7.50 | $15.0K | 2,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2017-02-28 | 2017-03-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2016-01-19 | 2016-01-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2015-01-26 | 2015-01-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2014-01-27 | 2014-01-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CRIS CURIS INC | P Buy | 2013-11-08 | 2013-11-08 | 20,000 | $2.95 | $59.0K | 30,000 | SEC↗ |
| CRIS CURIS INC | P Buy | 2013-09-16 | 2013-11-08 | 10,000 | $4.37 | $43.7K | 10,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2013-03-28 | 2013-03-28 | 25,000 | — | $0 | 25,000 | SEC↗ |